Best Tesamorelin Providers in 2026 — Ranked & Reviewed
Full FDA approval belongs to exactly one growth-hormone-releasing-hormone analog: tesamorelin, sold under the brand name Egrifta, with phase 3 trial data behind it for reducing visceral abdominal fat in HIV-associated lipodystrophy. It is compounded and prescribed off-label as well, more broadly, for body composition and GH support. A prescription is required. Every provider below prescribes through a licensed clinician, and every one carries a score on our six standard dimensions.
Lowest verified price: $199/mo10 providers compared
New to Tesamorelin? Read our full Tesamorelin guide — evidence, dosing, safety and side effects.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
10 tesamorelin providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
semaglutide at $99/month, 48% under the register median
From /mo$199Coverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelin bloodwork inside the $99/month rather than billed on top
From /moCheck pricingCoverage36 statesMedicationsBPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelin- Best Budget
knowing which pharmacy fills the vial — it names VialsRX
From /mo$299Coverage50 statesMedicationsNAD+GlutathioneTesamorelin - Nationwide Coverage
coverage in all 50 states, which most of the register will not confirm
From /moCheck pricingCoverage50 statesMedicationsCJC-1295 / IpamorelinGHK-CuGlutathioneNAD+SermorelinTesamorelin seeing what it charges before you answer any medical questions
From /mo$399CoverageCheck intakeMedicationsSermorelinTesamorelinBPC-157kpvGHK-CuNAD+MOTS-ca published state list — 28 of 50 — when most of the register publishes none
From /moCheck pricingCoverage28 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneGonadorelinIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin- Best Care Team
coaching inside the $299/month rather than sold separately
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+SermorelinTesamorelin - From /moCheck pricingCoverageCheck intakeMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinTB-500Tesamorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick semaglutide at $99/month, 48% under the register median | $199 | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelin | 50 states | Visit → | |
 bloodwork inside the $99/month rather than billed on top | Check pricing | BPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelin | 36 states | Visit → | |
Best Budget knowing which pharmacy fills the vial — it names VialsRX | $299 | NAD+GlutathioneTesamorelin | 50 states | Visit → | |
Nationwide Coverage coverage in all 50 states, which most of the register will not confirm | Check pricing | CJC-1295 / IpamorelinGHK-CuGlutathioneNAD+SermorelinTesamorelin | 50 states | Visit → | |
 seeing what it charges before you answer any medical questions | $399 | SermorelinTesamorelinBPC-157kpvGHK-CuNAD+MOTS-c | Check intake | Visit → | |
 a published state list — 28 of 50 — when most of the register publishes none | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneGonadorelinIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin | 28 states | Visit → | |
Best Care Team coaching inside the $299/month rather than sold separately | Check pricing | GHK-CuGlutathioneNAD+SermorelinTesamorelin | Check intake | Visit → | |
 | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinTB-500Tesamorelin | Check intake | Visit → |
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Detailed Reviews
About the prices below: every dollar figure inside these provider summaries belongs to that clinic’s GLP‑1 weight-loss program. None is a Tesamorelin price. For Tesamorelin itself, read the figure next to each clinic in the comparison table above, taken from the clinic’s own product page. A reading of “Check pricing” means the clinic does prescribe Tesamorelin and publishes nothing for it, so you are quoted after your consultation.
Live Vital
Verified partnerBest for: semaglutide at $99/month, 48% under the register median
Billed in 3-month blocks, the compounded GLP-1 semaglutide starts at $99/mo and compounded tirzepatide at $183/mo. Dr. Patrick Taylor, MD founded the practice and every plan is written by a doctor, filled at a licensed US pharmacy and delivered to the door. Messaging the care team has no cap and nothing locks you in. Peptide and hormone therapy round out the menu. Telehealth reaches all 50 states.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $183 a month, 31% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its retatrutide and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Pepti
Best for: bloodwork inside the $99/month rather than billed on top
One flat charge holds regardless of dose: $99 a month for injectable semaglutide, $199 for tirzepatide, each figure covering shipping, refill management, baseline labs, physician review and the drug itself. Registered in Delaware, the platform reaches 36 states with doctor-prescribed compounded peptides and GLP-1s, and its catalog passes 120 products spanning skin, cognitive, recovery, TRT and hormone, and weight-loss categories, bloodwork at home included. Insurance is not billed. Pepti prescribes nothing itself; it is the platform.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping, labs
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗Coverage is published for 36 states only, so this may not reach you
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Trellis Vitality
Best for: knowing which pharmacy fills the vial — it names VialsRX
$150 a month opens compounded semaglutide and $199 compounded tirzepatide, identical at every dose, with no consult fee or membership stacked on top. Scale weight is not the frame; body composition is, which is why biomarker panels taken at home, a re-test at 90 days, and muscle-sparing choices such as glycine formulations and tesamorelin come with the GLP-1s. Trellis does the coordinating only: VialsRX in Houston dispenses and the Arora Health provider network prescribes.
Score Breakdown
Pros
- ✓Semaglutide at $150 a month, within the normal band around this register's $189 median for the same drug and form
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓Names VialsRX as the dispensing pharmacy, which most sellers in this register do not do
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Dr. Gillis' Wellness Center
Best for: coverage in all 50 states, which most of the register will not confirm
Start a semaglutide dose and it costs $150; the monthly plans below that open at $149, with no contract and scheduling you can set weekly, bi-weekly or monthly. Three GLP-1 molecules are written, semaglutide, tirzepatide and retatrutide, each as an injection or a sublingual ODT, the orally dissolving tablet that matters if needles are the obstacle. The clinic sits in Oakland, Maine and sells telehealth countrywide. Dr. Gillis leads it, board-certified as physician and surgeon, 25-plus years into gut health, and a serving member of the Maine State Medical Board.
Score Breakdown
Pros
- ✓Semaglutide at $149 a month, within the normal band around this register's $189 median for the same drug and form
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Rehydra+ Wellness
Best for: seeing what it charges before you answer any medical questions
Dose drives the tier here, so the subscription climbs as you titrate. Paramedics and nurses started the business as mobile IV therapy in San Antonio, Texas, and it now lists compounded semaglutide and tirzepatide beside GHK-Cu, sermorelin, tesamorelin, MOTS-C, KPV and BPC-157, a Lipo-Plus lipotropic shot, NAD+ and testosterone therapy. Consultations cost nothing, the storefront shows its prices, and payment can be financed. The company claims 20 states; the states themselves are never listed.
Score Breakdown
Pros
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No state list is on record here, so whether it serves your state cannot be confirmed from this page
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.